301335-39-7 Usage
Uses
Used in Pharmaceutical Research and Development:
3-Phenoxy-azetidinehydrochloride is used as a building block for the synthesis of various biologically active compounds, contributing to the advancement of new drug formulations and therapies.
Used in Epilepsy Treatment:
3-Phenoxy-azetidinehydrochloride is used as a potential anticonvulsant agent for the development of drugs targeting the treatment of epilepsy, due to its reported ability to control seizures.
Used in Pain Management:
3-Phenoxy-azetidinehydrochloride is used as an antinociceptive agent, indicating its potential role in the development of drugs for pain management, particularly for conditions that require novel therapeutic approaches.
Check Digit Verification of cas no
The CAS Registry Mumber 301335-39-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,1,3,3 and 5 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 301335-39:
(8*3)+(7*0)+(6*1)+(5*3)+(4*3)+(3*5)+(2*3)+(1*9)=87
87 % 10 = 7
So 301335-39-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO.ClH/c1-2-4-8(5-3-1)11-9-6-10-7-9;/h1-5,9-10H,6-7H2;1H
301335-39-7Relevant academic research and scientific papers
PDE9I WITH IMIDAZO PYRAZINONE BACKBONE
-
Page/Page column 38; 39, (2013/04/25)
This invention is directed to compounds, which are PDE9 enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The pres
NOVEL HETEROCYCLIC ACRYLAMIDES AND THEIR USE AS PHARMACEUTICALS
-
Page/Page column 42-43, (2011/06/19)
The invention relates to novel heterocyclic acrylamide compounds (I), to the preparation of the compounds and intermediates used therein, to the use of the compounds as antibacterial medicaments and pharmaceutical compositions containing the compounds.
CARBOXAMIDE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS
-
Page/Page column 61, (2008/06/13)
The invention relates to compounds of Formula (I) processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.
